| RU2262951C2 (en)* | 2003-02-05 | 2005-10-27 | Консультативно-диагностическая поликлиника аллергологии и клинической иммунологии | Method for predicting complications of immunotherapy with allergens in case of seasonal allergic rhinitis |
| JP4851944B2 (en)* | 2003-12-23 | 2012-01-11 | ジェネンテック， インコーポレイテッド | Novel anti-IL13 antibody and use thereof |
| AR049390A1 (en)* | 2004-06-09 | 2006-07-26 | Wyeth Corp | ANTIBODIES AGAINST HUMAN INTERLEUQUINE-13 AND USES OF THE SAME |
| RU2317330C2 (en)* | 2006-01-16 | 2008-02-20 | Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" | RECOMBINANT PLASMID DNA pcL37 ENCODING POLYPEPTIDE WITH PROPERTIES OF HUMAN LIGHT CHAIN OF ANTIBODY AGAINST SMALLPOX VIRUS VACCINE, RECOMBINANT PLASMID DNA pcH37 ENCODING POLYPEPTIDE WITH PROPERTIES OF HEAVY CHAIN OF INDICATED ANTIBODY AND THEIR USING |
| UA98943C2 (en)* | 2006-10-02 | 2012-07-10 | Ридженерон Фармасьютикалз, Инк. | High affinity human antibodies to human il-4 receptor |
| US7608693B2 (en)* | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| EP2050764A1 (en)* | 2007-10-15 | 2009-04-22 | sanofi-aventis | Novel polyvalent bispecific antibody format and uses thereof |
| EP2245064B1 (en)* | 2007-12-21 | 2014-07-23 | Medimmune Limited | BINDING MEMBERS FOR INTERLEUKIN-4 RECEPTOR ALPHA (IL-4Ralpha) |
| JP6306588B2 (en) | 2012-08-21 | 2018-04-04 | サノフィ・バイオテクノロジー | Method for treating or preventing asthma by administering an IL-4R antagonist |
| TWI697334B (en) | 2013-06-04 | 2020-07-01 | 美商再生元醫藥公司 | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor |
| TWI634900B (en) | 2013-07-11 | 2018-09-11 | 再生元醫藥公司 | Method for treating eosinophilic esophagitis by administering an IL-4R inhibitor |
| KR20160120735A (en) | 2014-02-28 | 2016-10-18 | 리제너론 파아마슈티컬스, 인크. | Methods for treating skin infection by administering an il-4r antagonist |
| RU2734490C2 (en) | 2014-11-14 | 2020-10-19 | Санофи Байотекнолоджи | Methods of treating chronic sinusitis with nasal polyps by administering il-4r antagonist |
| EP4442323A3 (en) | 2016-09-01 | 2025-01-01 | Regeneron Pharmaceuticals, Inc. | Methods for preventing or treating allergy by administering an il-4r antagonist |
| TWI857389B (en) | 2016-12-01 | 2024-10-01 | 美商再生元醫藥公司 | Methods of treating inflammatory conditions |
| WO2019028367A1 (en) | 2017-08-04 | 2019-02-07 | Regeneron Pharmaceuticals, Inc. | Methods for treating active eosinophilic esophagitis |
| MA46269B1 (en) | 2017-08-18 | 2024-05-31 | Regeneron Pharma | METHODS OF TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTRATION OF AN IL-4R INHIBITOR |
| JP7315545B2 (en) | 2017-10-30 | 2023-07-26 | サノフィ・バイオテクノロジー | Methods for treating or preventing asthma by administering an IL-4R antagonist |
| CA3099066A1 (en) | 2018-05-13 | 2019-11-21 | Regeneron Pharmaceuticals, Inc. | Methods for treating atopic dermatitis by administering an il-4r inhibitor |
| WO2020191346A1 (en) | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
| KR20220034878A (en) | 2019-07-16 | 2022-03-18 | 사노피 바이오테크놀로지 | Methods of treating or preventing asthma by administering an IL-4R antagonist |
| KR20220044563A (en) | 2019-08-05 | 2022-04-08 | 리제너론 파아마슈티컬스, 인크. | A method for treating atopic dermatitis by administering an IL-4R antagonist |
| BR112022000581A2 (en) | 2019-08-05 | 2022-03-03 | Regeneron Pharma | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonist |